IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-41065-4.html
   My bibliography  Save this article

Orai inhibition modulates pulmonary ILC2 metabolism and alleviates airway hyperreactivity in murine and humanized models

Author

Listed:
  • Emily Howard

    (University of Southern California)

  • Benjamin P. Hurrell

    (University of Southern California)

  • Doumet Georges Helou

    (University of Southern California)

  • Pedram Shafiei-Jahani

    (University of Southern California)

  • Spyridon Hasiakos

    (University of California)

  • Jacob Painter

    (University of Southern California)

  • Sonal Srikanth

    (University of California)

  • Yousang Gwack

    (University of California)

  • Omid Akbari

    (University of Southern California)

Abstract

Ca2+ entry via Ca2+ release-activated Ca2+ (CRAC) channels is a predominant mechanism of intracellular Ca2+ elevation in immune cells. Here we show the immunoregulatory role of CRAC channel components Orai1 and Orai2 in Group 2 innate lymphoid cells (ILC2s), that play crucial roles in the induction of type 2 inflammation. We find that blocking or genetic ablation of Orai1 and Orai2 downregulates ILC2 effector function and cytokine production, consequently ameliorating the development of ILC2-mediated airway inflammation in multiple murine models. Mechanistically, ILC2 metabolic and mitochondrial homeostasis are inhibited and lead to the upregulation of reactive oxygen species production. We confirm our findings in human ILC2s, as blocking Orai1 and Orai2 prevents the development of airway hyperreactivity in humanized mice. Our findings have a broad impact on the basic understanding of Ca2+ signaling in ILC2 biology, providing potential insights into the development of therapies for the treatment of allergic and atopic inflammatory diseases.

Suggested Citation

  • Emily Howard & Benjamin P. Hurrell & Doumet Georges Helou & Pedram Shafiei-Jahani & Spyridon Hasiakos & Jacob Painter & Sonal Srikanth & Yousang Gwack & Omid Akbari, 2023. "Orai inhibition modulates pulmonary ILC2 metabolism and alleviates airway hyperreactivity in murine and humanized models," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41065-4
    DOI: 10.1038/s41467-023-41065-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-41065-4
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-41065-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Martin Vaeth & Jun Yang & Megumi Yamashita & Isabelle Zee & Miriam Eckstein & Camille Knosp & Ulrike Kaufmann & Peter Karoly Jani & Rodrigo S. Lacruz & Veit Flockerzi & Imre Kacskovics & Murali Prakri, 2017. "ORAI2 modulates store-operated calcium entry and T cell-mediated immunity," Nature Communications, Nature, vol. 8(1), pages 1-17, April.
    2. Doumet Georges Helou & Pedram Shafiei-Jahani & Richard Lo & Emily Howard & Benjamin P. Hurrell & Lauriane Galle-Treger & Jacob D. Painter & Gavin Lewis & Pejman Soroosh & Arlene H. Sharpe & Omid Akbar, 2020. "PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity," Nature Communications, Nature, vol. 11(1), pages 1-15, December.
    3. Lauriane Galle-Treger & Yuzo Suzuki & Nisheel Patel & Ishwarya Sankaranarayanan & Jennifer L. Aron & Hadi Maazi & Lin Chen & Omid Akbari, 2016. "Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity," Nature Communications, Nature, vol. 7(1), pages 1-13, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Yiyi Ma & Eric B. Dammer & Daniel Felsky & Duc M. Duong & Hans-Ulrich Klein & Charles C. White & Maotian Zhou & Benjamin A. Logsdon & Cristin McCabe & Jishu Xu & Minghui Wang & Thomas S. Wingo & James, 2021. "Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue," Nature Communications, Nature, vol. 12(1), pages 1-16, December.
    2. Thomas Hollin & Steven Abel & Alejandra Falla & Charisse Flerida A. Pasaje & Anil Bhatia & Manhoi Hur & Jay S. Kirkwood & Anita Saraf & Jacques Prudhomme & Amancio De Souza & Laurence Florens & Jacqui, 2022. "Functional genomics of RAP proteins and their role in mitoribosome regulation in Plasmodium falciparum," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Lauriane Galle-Treger & Doumet Georges Helou & Christine Quach & Emily Howard & Benjamin P. Hurrell & German R. Aleman Muench & Pedram Shafiei-Jahani & Jacob D. Painter & Andrea Iorga & Lily Dara & Ju, 2022. "Autophagy impairment in liver CD11c+ cells promotes non-alcoholic fatty liver disease through production of IL-23," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    4. Kaifan Bao & Xiaoqun Gu & Yajun Song & Yijing Zhou & Yanyan Chen & Xi Yu & Weiyuan Yuan & Liyun Shi & Jie Zheng & Min Hong, 2024. "TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    5. Jongho Ham & Jihyun Kim & Kyoung-Hee Sohn & In-Won Park & Byoung-Whui Choi & Doo Hyun Chung & Sang-Heon Cho & Hye Ryun Kang & Jae-Woo Jung & Hye Young Kim, 2022. "Cigarette smoke aggravates asthma by inducing memory-like type 3 innate lymphoid cells," Nature Communications, Nature, vol. 13(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41065-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.